
A steady large-cap cyclical trading near fair value. Most frameworks reject it today.
Mkt Cap
$61.01B
P/E
—
PEG
0.82
P/B
1.93
Dividend
2.83%
ROE
5.7%
About the business
Sempra engages in the regulated utilities business in the United States and Mexico. It operates through three segments: Sempra California, Sempra Texas Utilities, and Sempra Infrastructure. It also invests in and operates electric and gas utilities and other energy infrastructure that provides energy services to customers. The Sempra California segment provides natural gas and electric services to Southern California and part of central California. As of December 31, 2025, it offered electric services to approximately 3.6 million population and natural gas services to approximately 3.3 million population that covers 4,100 square miles. This segment owns and operates a natural gas distribution, transmission, and storage system that supplies natural gas. As of December 31, 2025, it served a population of 21.3 million covering an area of 24,000 square miles. The Sempra Texas Utilities segment engages in the regulated electricity transmission and distribution utility business. As of December 31, 2025, transmission system included approximately 18,418 circuit miles of transmission lines; 1,333 transmission and distribution substations; interconnection to 230 third-party generation facilities totaling 63,670 MW; and distribution system included more than 4.1 million points of delivery and consisted of 127,398 circuit miles of overhead and underground lines. The Sempra Infrastructure segment develops, constructs, operates, and invests in energy infrastructure to help enable the access to cleaner energy in markets in the United States, Mexico, and internationally. The company was formerly known as Sempra Energy and changed its name to Sempra in May 2023. Sempra was incorporated in 1996 and is headquartered in San Diego, California.
Who would buy SRE?
Consensus 3/100 · Aligned · Investors mostly agree.
Endorses
· 0 frameworksNo framework reaches a strong endorsement at current metrics.
Rejects
· 3 frameworksRevenue Growth > 15% is -3.9% — fails "> 15.0%".
Net Cash Positive (NCAV proxy) is $-54.52 — fails "> $0.00".
5 insiders sold $6.8M on a discretionary basis. Discretionary selling carries more signal than planned disposals, but insiders sell for many non-thesis reasons (taxes, diversification, life events) — do not over-read it. Over the 6M window, insiders are net buyers by 13,073 shares.
In Prism's context
Insider selling is worth flagging but insiders sell for many non-thesis reasons. Read alongside the framework verdict (Fails criteria).
| Insider | Role | Type | Date | Shares | Avg price | Value | Own |
|---|---|---|---|---|---|---|---|
| BIRD JUSTIN CHRISTOPHER | Officer | Open-market sell | Apr 1, 2026 | 1,128 | $96.69 | $109K | Direct |
| WOLD DYAN Z. | Officer | Open-market sell | Mar 16, 2026 | 1,539 | $95.38 | $147K | Direct |
| KIRK JENNIFER M | Director | Open-market buy | Mar 12, 2026 | 1,000 | $93.44 | $93K | Direct |
| MARK RICHARD J | Director | Open-market buy | Mar 11, 2026 | 2,692 | $93.30 | $251K | Direct |
| WARNER CYNTHIA J | Director | Open-market buy | Mar 11, 2026 | 2,500 | $92.95 | $232K | Direct |
| SEDGWICK KAREN L | Chief Financial Officer | Open-market sell | Mar 9, 2026 | 4,872 | $92.58 | $451K | Direct |
| MARTIN JEFFREY W | Chief Executive Officer | Award / grant | Jan 27, 2026 | 38,264 | $0.00 | $0 | Direct |
| SAGARA KEVIN C | Director | Award / grant | Jan 27, 2026 | 7,453 | $0.00 | $0 | Direct |
| SEDGWICK KAREN L | Chief Financial Officer | Award / grant | Jan 27, 2026 | 5,152 | $0.00 | $0 | Direct |
| WINN CAROLINE ANN | Officer | Award / grant | Jan 27, 2026 | 4,526 | $0.00 | $0 | Direct |
| DAY DIANA L | Officer | Award / grant | Jan 27, 2026 | 1,804 | $0.00 | $0 | Direct |
| BIRD JUSTIN CHRISTOPHER | Officer | Award / grant | Jan 27, 2026 | 4,924 | $0.00 | $0 | Direct |
| LARROQUE ALEXANDER LISA | Officer | Award / grant | Jan 27, 2026 | 1,666 | $0.00 | $0 | Direct |
| WOLD DYAN Z. | Officer | Award / grant | Jan 27, 2026 | 736 | $0.00 | $0 | Direct |
| MARTIN JEFFREY W | Chief Executive Officer | Open-market sell | Jan 5, 2026 | 53,111 | $88.39 | $4.69M | Direct |
| DAY DIANA L | Officer | Award / grant | Jan 2, 2026 | 9,364 | $0.00 | $0 | Direct |
| LARROQUE ALEXANDER LISA | Officer | Award / grant | Jan 2, 2026 | 5,824 | $0.00 | $0 | Direct |
| WOLD DYAN Z. | Officer | Award / grant | Jan 2, 2026 | 2,890 | $0.00 | $0 | Direct |
| SEDGWICK KAREN L | Chief Financial Officer | Open-market sell | Nov 24, 2025 | 7,564 | $92.29 | $698K | Direct |
| WINN CAROLINE ANN | Officer | Open-market sell | Nov 19, 2025 | 6,000 | $91.59 | $550K | Direct |
| WOLD DYAN Z. | Officer | Open-market sell | Nov 19, 2025 | 1,510 | $91.38 | $138K | Direct |
Insider activity from Yahoo Finance (quoteSummary: insiderTransactions + netSharePurchaseActivity). Cached 6 hours. · Insiders hold 0.1% of shares outstanding.
Net 6M: +13,073 sh
Price history
Drag across the chart to select a custom period — all analysis below refocuses to that window.
What this means: A significant rerating — the valuation-sensitive frameworks below will have tightened since this move.
Add Sempra at a hypothetical weight and Prism recalculates your whole book:
Sharpe, Sortino, volatility, max drawdown, beta — before and after.
How much this shifts your top sector weight and overall diversification.
Whether this leans your book more toward Quality, Value, Growth, Deep Value, Income, or Momentum.
Portfolio analytics are part of the member experience.
Sign in to run this simulationSRE: 45% estimated probability of outperforming over the next 12M window. 0 of 6 signal families negative (low confidence). Main risk to monitor: 89% above fair value.
Probabilistic research output, not financial advice. Prism recommendations are based on available data, historical relationships, and model assumptions. They do not guarantee future returns. Conduct independent due diligence before any investment decision.
Backtested and similar-setup statistics may be affected by survivorship bias, look-ahead bias, overfitting, transaction costs, liquidity constraints, and data limitations. Probability estimates are anchored heuristics — not validated forecasts — until the walk-forward backtest pipeline is in place.
P/B 1.93× · FCF yield -46.3%
89% above fair value
Indicative only. Probabilities are model-implied weights for stress-testing — not forecasts.
A turnaround takes hold: margin recovers toward peer averages, revenue stabilises, and the market re-prices the asset value rather than the running earnings.
No deterioration, no surprise re-acceleration. 31% operating margin and -4% top-line growth chug along; the multiple slowly converges to the central fair-value estimate.
Sector: Utilities. MENA-aware investors can sanity-check whether the US name is offering value relative to regional peers.
| Metric | SRE | GCC median | MENA median | Global ex-US |
|---|---|---|---|---|
| P/E (TTM) | — | 13.0× | — | 14.0× |
| P/B | 1.93× | 1.60× | — | 1.60× |
| Dividend yield | 2.83% | 4.80% | — | 4.60% |
| ROE | 5.7% |
Reported EPS $1.51 vs $1.02 expected — well outside the normal beat-and-raise band. The market typically rewards a print this size only if it is read as durable, not one-off. Trailing operating margin: 30.6%.
Confirms operating leverage — 14% trailing EPS growth + a beat of this size is the pattern that drives multi-year re-rates.
If ROE (6%) and operating margin (31%) are stable or rising, the beat is consistent with compounding rather than one-off.
Outsized beats on thin trailing quality often invite multiple expansion that doesn't survive the next print.
Next earnings
Thu, Aug 6 · consensus EPS $1.02 · last actual $1.51
Ciroos Expands AI SRE Capabilities to Tame Complexity and Noise in Enterprise Operations
GlobeNewswire · just now
Evercore ISI Adjusts Price Target on Sempra to $106 From $107
MT Newswires · just now
Assessing Sempra (SRE) Valuation As Investors Revisit The Stock After Recent Share Price Moves
Simply Wall St. · just now
P/E Ratio (TTM)
N/A
PEG Ratio
0.82
P/B Ratio
1.93
EPS Growth
13.7%
Revenue Growth
-3.9%
Debt / Equity
0.85
Net Cash / Share
$-54.52
Return on Equity
5.7%
Gross Margin
42.5%
Operating Margin
30.6%
FCF / Share
$-43.21
Current Ratio
1.69
P/B < 1.0 (below book) is 1.93× — fails "< 1.00×".
Trades meaningfully above the fair-value range — limited margin of safety.
Quality is mixed — some strengths, some softness.
Capital structure is unremarkable — neither a stress nor a tailwind.
Price trend is unremarkable — neither tailwind nor headwind.
Behavioural read is mixed — some accumulation, some distribution.
Mixed catalyst picture.
No positive drivers identified.
Among 94 historical setups with similar Prism Score and signal-agreement profiles, 48% beat the benchmark over the next 12 months, with average excess return of -1.1% / yr.
ROE 6% · Op margin 31%
D/E 0.85 · CR 1.69
7 insiders buying
No tracked superinvestor holds it
2.83% yield
72% through 52w range
EPS 14% · Rev -4%
Cyclical earnings prove to be at peak; revenue stalls and the multiple, already low, drifts lower as estimates re-rate down.
| — |
| 9.0% |
Institutional Own.
94.4%
Insider Own.
0.1%
Dividend Yield
2.83%
Book Value / Share
$48.40